SC
AVNS

Schubert & Co’s Avanos Medical AVNS Stock Holding History

Schubert & Co’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-27
Closed -$803 – 155
2023
Q1 		$803 Buy
27
+8
+42% +$232 ﹤0.01% 1285
2022
Q4 		$514 Buy
19
+9
+90% +$220 ﹤0.01% 1381
2022
Q3 		$0 Sell
10
-14
-58% -$366 ﹤0.01% 1372
2022
Q2 		$1K Buy
24
+13
+118% +$374 ﹤0.01% 985
2022
Q1 		$0 Buy
11
+5
+83% +$161 ﹤0.01% 1073
2021
Q4 		$0 Buy
+6
New +$194 ﹤0.01% 1008

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Schubert & Co's AVNS Position: Q2 2023 in Review

Schubert & Co sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 27 shares — an estimated $803 sold.

Schubert & Co first reported a position in AVNS in Q4 2021 and held it in 6 quarters. The position peaked at $1K in Q2 2022. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.

  • Schubert & Co reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 27 Avanos Medical shares in Q2 2023, an estimated $803.
  • Schubert & Co first reported a position in Avanos Medical in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Avanos Medical position peaked at $1K in Q2 2022.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.